REPLIGEN CORP — Form 10-Q
Filed October 30, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 8/100
What the filing says
This filing contains only routine officer certifications (Exhibits 31.1, 31.2, and 32.1) dated October 30, 2026, signed by CEO Olivier Loeillot and CFO Jason K. Garland. The exhibits are standard Sarbanes-Oxley attestations regarding disclosure controls, internal controls over financial reporting, and financial statement accuracy. No substantive business transactions, financial results, guidance changes, acquisitions, divestitures, or operational developments are present in the provided text.
Why this rating
Boilerplate SEC certification exhibit; no business events or material developments disclosed. Routine compliance filing.
See more from October 30, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.